Home/All Molecules/Terbutaline

Terbutaline Range

Comprehensive Terbutaline portfolio for Franchise & Manufacturing.

Category
terbutaline
Total Formulations
12
Available Forms
Drop, Syrup, Tablets

Expand Your Business with Our Multiple Divisions


Browse Terbutaline portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Terbutaline batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Terbutaline PCD Pharma Franchise Company

Terbutaline PCD Pharma Franchise Company

Cafoli Lifecare is a dependable Terbutaline PCD pharma franchise company in India, offering 12 Terbutaline formulations across syrups, drops and tablets, including the expectorant and mucolytic combinations that dominate everyday respiratory prescribing. All are manufactured at WHO-GMP certified facilities with DCGI-approved compositions.

What is Terbutaline?

Terbutaline is a selective short-acting beta-2 adrenergic agonist. By stimulating beta-2 receptors on bronchial smooth muscle it raises intracellular cyclic AMP, relaxing the airway muscle and relieving bronchospasm. Its selectivity for beta-2 over beta-1 receptors means it dilates the airways with comparatively limited cardiac stimulation. Compound information is catalogued on PubChem.

Therapeutic Applications of Terbutaline

Terbutaline is used for the relief of bronchospasm in bronchial asthma, chronic bronchitis, emphysema and other obstructive airway disease, and is very widely prescribed in India within combination cough syrups for productive cough associated with bronchospasm. Prescribers include pulmonologists and chest physicians, paediatricians, ENT specialists and general practitioners. It is a prescription medicine and should be used under medical supervision.

Why Terbutaline is a High-Potential Molecule for Distributors

The commercial reality of terbutaline in India is that it sells as a cough syrup ingredient far more than as a standalone bronchodilator. Paired with guaiphenesin, ambroxol or bromhexine, it sits inside some of the fastest-moving syrups in general and paediatric practice, and cough preparations are among the highest-turnover categories a distributor can hold. Volumes surge every winter and during urban air-quality peaks, when respiratory consultations climb steeply, and paediatric drops and syrups add a second, reliably recurring channel. It is a high-rotation, low-value-per-unit line that keeps a territory's monthly billing consistent.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers genuine district monopoly rights, WHO-GMP certified manufacturing, DCGI-approved compositions and complete promotional inputs including visual aids, samples, prescription pads, MR bags and doctor gifts. Over 1000+ franchise partners across India work with us.

References

  1. PubChem – Terbutaline compound record
  2. MedlinePlus – Terbutaline drug information
  3. PubMed – clinical literature on Terbutaline

Aceclofenac in Modern Clinical Practice

Our formulations of Terbutaline find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Terbutaline in PCD Franchise

Start Your Terbutaline Franchise with Cafoli Lifecare

Ready to build your own Terbutaline distribution business? Cafoli Lifecare offers monopoly-based PCD pharma franchise rights, WHO-GMP certified manufacturing and complete promotional support. Call 9518447302 or email info@cafoli.in to check district availability and receive our latest price list.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare lists 12 Terbutaline formulations across syrups, drops and tablets, including the expectorant and mucolytic combinations widely used in cough and bronchospasm. The composition-wise list with packing and pricing is shared on enquiry.

Yes. Terbutaline is offered on a district monopoly basis, so only one Cafoli franchise partner is appointed per territory, subject to verification of your Drug License.

Terbutaline is prescribed by pulmonologists and chest physicians, and very heavily by paediatricians and general practitioners for cough with bronchospasm, asthma and bronchitis.

Most of the volume comes from combination cough preparations rather than plain bronchodilator use. Terbutaline is formulated with expectorants and mucolytics such as guaiphenesin, ambroxol and bromhexine, and these syrups are among the highest-turnover items in Indian general and paediatric practice. Demand also rises sharply during winter and pollution peaks, giving a strong seasonal uplift.

A valid Drug License and GST registration number are required to begin the appointment process with Cafoli Lifecare.